Disease-Modifying Effects of a Novel Cathepsin K Inhibitor in Osteoarthritis

Preclinical studies suggest that MIV-711, a selective and reversible cathepsin K inhibitor, has beneficial effects on bone and cartilage. This phase 2a randomized controlled trial examined the effi...